Imagion Biosystems Limited
IBXXF
$0.01
$0.00-10.71%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 89.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 89.02% | |||
| Cost of Revenue | 0.31% | 149.00% | |||
| Gross Profit | -0.32% | -151.62% | |||
| SG&A Expenses | 0.34% | 65.96% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.32% | 108.86% | |||
| Operating Income | -0.32% | -109.30% | |||
| Income Before Tax | -0.32% | -62.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.32% | -62.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.32% | -62.76% | |||
| EBIT | -0.32% | -109.30% | |||
| EBITDA | -0.31% | -109.77% | |||
| EPS Basic | 0.00% | 3.85% | |||
| Normalized Basic EPS | 0.00% | 11.76% | |||
| EPS Diluted | 0.00% | 7.41% | |||
| Normalized Diluted EPS | 0.00% | 11.76% | |||
| Average Basic Shares Outstanding | 0.00% | 75.62% | |||
| Average Diluted Shares Outstanding | 0.00% | 75.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||